DNLI - Denali Therapeutics GAAP EPS of -$0.75 beats by $0.03 revenue of $10.28M misses by $1.01M
- Denali Therapeutics press release ( NASDAQ: DNLI ): Q4 GAAP EPS of -$0.75 beats by $0.03 .
- Revenue of $10.28M (-17.8% Y/Y) misses by $1.01M .
For further details see:
Denali Therapeutics GAAP EPS of -$0.75 beats by $0.03, revenue of $10.28M misses by $1.01M